Edwards Lifesciences Corp. announced that a federal jury in Boston returned a verdict in favor of CardiAQ in a lawsuit filed against a former service provider, Neovasc.

A new technique for cardiac magnetic resonance (CMR) imaging improves accuracy by removing patients' need to breathe, reveals research presented at EuroCMR 2016.

First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict which coronary plaques have the potential to rupture.

Mitralign Inc. announced it has raised $39.8 million to date in a Series E equity round of financing.

Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher mortality rates and a greater risk of recurrent heart failure after transcatheter aortic valve replacement (TAVR).

Using optimal frequency domain imaging (OFDI) to guide percutaneous coronary intervention (PCI) with second-generation drug eluting stents (DES) achieves equivalent clinical and angiographic outcomes to intravascular ultrasound (IVUS)-guided PCI at 12 months.

Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision support tool to assist physicians and patients with decisions about blood thinning treatment to prevent strokes in individuals with atrial fibrillation.